Bandhan Healthcare Fund - Regular Plan - IDCW
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 10-11-2025
AUM:
₹ 0 Cr
Expense Ratio
2.38%
Benchmark
BSE Healthcare TRI
ISIN
INF194KB1KD0
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Mr. Viraj Kulkarni, Mr. Brijesh Shah, Ms. Ritika Behera and Mr. Gaurav Satra
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Bandhan Healthcare Fund - Regular Plan - IDCW | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
9.743
Last change
-0.05 (-0.5337%)
Fund Size (AUM)
₹ 0 Cr
Performance
-2.14% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. Disclaimer: There is no assurance or guarantee that the scheme’s objectives will be realised.
Fund Manager
Mr. Viraj Kulkarni, Mr. Brijesh Shah, Ms. Ritika Behera and Mr. Gaurav Satra
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Triparty Repo TRP_011225 | 41.62 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.05 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.55 |
| Dr. Reddys Laboratories Ltd | 6.48 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.3 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 6.18 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.55 |
| JB Chemicals & Pharmaceuticals Limited | 4.25 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 2.85 |
| SYNGENE INTERNATIONAL LIMITED EQ | 2.78 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 73.81 |